Seòmar agus comataidhean

We have noted the trial based in Wales, which is offering blood tests to people who have recovered from bowel cancer. We will consider of the results of this trial once it has concluded to determine whether it has evidenced benefit for patients.

On 1 January 2023, a one dose schedule was introduced in Scotland for all those eligible in the HPV vaccination programme up to their 25th birthday. We envisage that this programme change will increase the amount of people completing their vaccination schedule as it will remove the requirement to be recalled to receive a second dose.

We have outlined to Health Boards that some of the resource freed up due to the reduction in vaccination sessions due to the change to a one dose schedule should be re-directed to interventions that strengthen programme delivery, increase coverage rates and reduce inequalities.

Therefore, if someone misses their HPV vaccination, for whatever reason, there will be further opportunities to get it up to their 25th birthday. For example, some young people may be offered a rescheduled vaccination appointment within the next academic year.

I refer the member to the answer to question S6W-15497 on 16 March 2023. All answers to written Parliamentary Questions are available on the Parliament's website, the search facility for which can be found at https://www.parliament.scot/chamber-and-committees/written-questions-and-answers

On 1 January 2023, a one dose schedule was introduced in Scotland for all those eligible in the HPV vaccination programme up to their 25th birthday. We envisage that this programme change will increase the amount of people completing their vaccination schedule as it will remove the requirement to be recalled to receive a second dose.

We have outlined to Health Boards that some of the resource freed up due to the reduction in vaccination sessions due to the change to a one dose schedule should be re-directed to interventions that strengthen programme delivery, increase coverage rates and reduce inequalities.

Additionally, we have developed a dashboard which allows us to interrogate deprivation data further which will allow us to work with PHS and Health Boards to support these groups and encourage HPV vaccination and wider vaccination services.

There were 2,014 people in receipt of an Independent Living Fund award at the end of February 2023.

(a) In 2014, the Deputy First Minister committed to re-opening the Fund and provided £5.5 million per annum to enable ILF to re-open to new applicants for the first time since 2010.Through an extensive process of co-production, the ILF Scotland Transition Fund was developed as an alternative to re-opening the 2015 Fund. The Transition Fund was designed to support young disabled people with the transition to adult life. This entirely new fund opened to applications in December 2017.

(b) The Cabinet Secretary wrote to the ILF Scotland Board on 16 December 2022, 26 January 2023 and 27 February 2023 stating his support for ILF Scotland but indicating that re-opening the 2015 Fund could only progress when affordability and sustainability could be assured.

The Minister for Mental Wellbeing and Social Care wrote to the Chair of ILF Scotland’s Advisory Group on 23 January 2023 stating that he remains committed to re-opening the 2015 Fund but is unable to do so due to financial constraints.

The Scottish Government is committed to re-opening the 2015 Fund when affordability and sustainability can be assured. We will continue to actively consider re-opening the Fund as part of the annual budget setting process.

The Scottish Government is committed to improving the awareness of cervical cancer. In doing so we will continue to encourage those eligible to take the HPV vaccination and engage with the national cervical screening programme. We are continuing to take steps towards the World Health Organisation’s targets to eliminate cervical cancer.

The HPV vaccine continues to be offered to all pupils across Scotland via routine immunisation in early secondary school, from S1, through the school-based programme. From 1st January 2023, a one dose schedule was introduced for all those eligible in the programme up to their 25th birthday.

The screening programme in Scotland is routinely offered to anyone with a cervix, between the ages of 25 and 64, every five years.

Treatment for cancer, including cervical cancer, continues to be prioritised within NHS Scotland. We are developing a new 10 year cancer strategy which will launch in Spring 2023, and take a comprehensive approach to improving patient pathways from prevention and diagnosis through to treatment and post-treatment care.

The Glasgow Lighthouse Lab is contracted by the UK Government until March 2023 to undertake processing of PCR tests as part of the COVID-19 Infection survey (CIS). The CIS is outwith the control of the Scottish Government but officials are engaging with the UK Government and other devolved nations on its future. While no direct discussions have recently taken place between Scottish Ministers and representatives of the Lighthouse Lab, Scottish Government officials have been in contact with the University of Glasgow and also met with representatives of UNITE on 10 January to discuss recent developments.

As a result of the 22-23 Emergency Budget Review genomics was allocated a revised budget of £5 million, which has been sustained for 23-24.